By G HossainPosted on September 2, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The French giant is gaining access to darovasertib, a small molecule protein kinase C inhibitor already in Phase II/III trials, with rights for the whole world besides the U.S. Servier Commits up to $530M Into Eye Cancer Deal With IDEAYA Post navigation Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s ProgramVertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact